DEA, HHS issue another extension for telehealth controlled substance prescribing

Healthcare DIVE November 18, 2024
Emily Olsen

The third temporary extension, which prolongs the pandemic-era flexibilities through the end of 2025, is a relief for telehealth groups who had raised concerns about access to medications.

Dive Brief:

• The Drug Enforcement Administration and the HHS are extending flexibilities for providers prescribing controlled substances via telehealth for another year, the agencies said Friday.
• The temporary extension marks the third time regulators have prolonged the pandemic-era flexibilities, which allow providers to prescribe some controlled medications, like Adderall for ADHD or drugs to treat opioid use disorder, without first conducting an in-person evaluation.
• Telehealth groups applauded the temporary rule. Advocates had been concerned regulators might miss a year-end deadline to extend the flexibilities again or propose more stringent...

Today's Sponsors

Today's Sponsor